DavidWHaasMD
Infectious Disease • Nashville, TNProfessor, Medicine, Vanderbilt University School of Medicine
Dr. Haas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 1987 - 1988- Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1987
Vanderbilt University School of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body
- Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Start of enrollment: 2014 Jan 01
- Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery Start of enrollment: 2014 Jul 02
- Join now to see all
Publications & Presentations
PubMed
- Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.Nia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, Rodney Dawson, Yoninah Cramer
Pharmacogenetics and Genomics. 2025-02-12 - Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.Gustavo Amorim, James Jaworski, Jing Yang, Marcelo Cordeiro-Santos, Afrânio L Kritski
Pharmacogenetics and Genomics. 2025-02-01 - Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.George W Nelson, Janine van Duijn, Yuko Yuki, Maria G Pau, Frank Tomaka
Journal of Virology. 2024-08-20
Press Mentions
Vanderbilt University Medical Center Seeks COVID-19 Patients for Participation in ACTIV-2 TrialApril 13th, 2021- Vanderbilt Seeks Volunteers for Clinical Trial to Find COVID-19 TreatmentsApril 12th, 2021
- Vanderbilt Seeks Volunteers for COVID-19 Clinical TrialApril 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
